METABOLIC HEALTH MD
CONDITIONS I TREAT
Metabolic conditions are often connected.
Obesity, insulin resistance, prediabetes, type 2 diabetes, high blood pressure, fatty liver, high triglycerides, gout, and other cardiometabolic problems frequently overlap. My goal is to identify the metabolic patterns connecting them and build a treatment plan around the individual patient.
I do not treat each diagnosis as if it exists in isolation.
COMMON METABOLIC CONDITIONS
These conditions often share overlapping metabolic drivers.
The diagnoses may look different on paper, but many occur together and can improve together when the underlying metabolic context is addressed.
INSULIN RESISTANCE + PREDIABETES
Insulin resistance can begin years before diabetes is diagnosed.
Insulin resistance means the body is becoming less responsive to insulin, often requiring higher insulin levels to maintain normal glucose. Blood sugar can remain “normal” for years while this process is developing.
​
Over time, insulin resistance may contribute to increasing waist circumference, higher triglycerides, fatty liver, elevated blood pressure, rising glucose, and eventually prediabetes or type 2 diabetes.
What I look for
Glucose and A1C
Useful, but they do not always show the earliest metabolic changes.
Fasting insulin
Can provide additional context about how much insulin is required to maintain glucose control.
Triglycerides, HDL, and waist circumference
Often help reveal the broader metabolic pattern.
Blood pressure, fatty liver, and other related findings
These may be part of the same underlying metabolic picture.
Treatment focuses on improving insulin sensitivity and reducing the metabolic burden through nutrition, weight and body-composition improvement, resistance training, sleep, movement, and medication when appropriate.
TYPE 2 DIABETES
Type 2 diabetes is more than a high blood sugar problem.
By the time type 2 diabetes is diagnosed, insulin resistance has often been developing for years. Rising glucose is an important part of the disease, but it does not tell the whole story.
​
Treatment should address glucose control while also improving the metabolic environment contributing to the disease, including excess body fat, insulin resistance, fatty liver, blood pressure, triglycerides, muscle mass, nutrition, sleep, and activity.
Lower glucose safely
Glucose may improve quickly when carbohydrate intake and medications change, so treatment needs to be monitored carefully and adjusted when necessary.
Improve insulin resistance
Nutrition, fat loss when needed, resistance training, muscle preservation, sleep, movement, and medication can all play a role in improving the underlying metabolic state.
Reassess medication needs
As glucose control improves, some diabetes medications may need to be reduced or changed to avoid hypoglycemia or overtreatment.
The goal is not simply a lower A1C. It is better metabolic health with safe, durable glucose control.
OBESITY + EXCESS WEIGHT
Weight is an outcome. The metabolic context matters.
Body weight is influenced by energy intake, but hunger, satiety, insulin resistance, food quality, muscle mass, sleep, medications, and the food environment all affect how easy or difficult weight regulation becomes.
​
My goal is not simply to make the scale move. I want excess body fat to come down while preserving or building muscle, improving metabolic markers, and making the eating pattern sustainable without constant hunger.
Hunger + satiety
A diet that leaves someone constantly hungry is difficult to sustain. Protein, food quality, carbohydrate intake, meal structure, and adequate nutrition all influence satiety.
Metabolic health
Weight change is more meaningful when glucose regulation, blood pressure, triglycerides, fatty liver, and other metabolic markers improve with it.
Body composition
Scale weight alone does not tell us whether someone is losing fat, muscle, or both. Waist circumference, strength, and lean mass provide important context.
Medication when useful
Anti-obesity medications can be valuable for selected patients, but they work best as part of a broader plan that also addresses nutrition, muscle, and metabolic health.
The goal is not simply weight loss. It is loss of excess body fat while protecting muscle and improving metabolic health.
HIGH BLOOD PRESSURE
A normal blood pressure on medication does not always mean the underlying physiology is normal.
High blood pressure can have many causes, but in a large number of patients it exists alongside insulin resistance, excess visceral fat, abnormal glucose regulation, sleep problems, and other features of metabolic dysfunction.
​
Medication can be necessary and effective. At the same time, I want to understand what may be contributing to the elevated blood pressure so treatment can address more than the number itself.
Metabolic context
I look at weight and waist circumference, glucose regulation, insulin resistance, triglycerides, sleep, activity, alcohol intake, and other factors that may be contributing to blood pressure elevation.
Home blood pressure data
Repeated home readings often provide a more useful picture than a single clinic measurement and help guide medication changes safely.
Medication adjustment
Blood pressure can fall as metabolic health improves, so medications may need to be reduced or adjusted to avoid dizziness, hypotension, or overtreatment.
The goal is controlled blood pressure and better metabolic health, with the least medication necessary to do that safely.
FATTY LIVER (MASLD)
Fatty liver is often a metabolic warning sign, not just a liver problem.
Metabolic dysfunction-associated steatotic liver disease often occurs alongside insulin resistance, excess visceral fat, elevated triglycerides, prediabetes, type 2 diabetes, and other cardiometabolic problems.
​
Liver enzymes can be normal even when excess fat is present in the liver, so the broader clinical picture matters. When appropriate, I use laboratory testing and imaging to assess liver health and metabolic risk more completely.
Liver enzymes
​ALT, AST, GGT, and related markers provide useful information, but normal values do not necessarily exclude fatty liver.
Imaging when appropriate
Ultrasound or other imaging may be useful to assess liver fat and look for additional liver abnormalities.
Metabolic context
Waist circumference, glucose regulation, triglycerides, insulin resistance, weight, and blood pressure help define the broader picture.
Treatment response
Changes in body composition, glucose regulation, triglycerides, liver enzymes, and imaging can help show whether the underlying metabolic state is improving.
The goal is not simply to normalize liver enzymes. It is to reduce the metabolic burden contributing to fat accumulation in the liver.
HIGH TRIGLYCERIDES + CHOLESTEROL
A lipid panel tells a story, but no single number tells the whole story.
High triglycerides commonly occur alongside insulin resistance, fatty liver, excess visceral fat, and impaired glucose regulation. They often improve substantially when the underlying metabolic state improves.
​
Cholesterol-related risk requires more context. I consider the pattern of triglycerides, HDL, LDL-related markers, ApoB when useful, blood pressure, glucose regulation, family history, smoking, inflammation, and other cardiovascular risk information rather than interpreting one value in isolation.
Triglycerides + HDL
Elevated triglycerides and low HDL can be important clues to insulin resistance and altered metabolic health, especially when viewed alongside waist circumference and glucose regulation.
ApoB + LDL-related markers
These provide information about circulating atherogenic particles and should be interpreted in the context of the patient’s overall cardiovascular risk rather than in isolation.
Cardiovascular risk context
Age, blood pressure, smoking, family history, metabolic health, inflammatory markers, and coronary artery calcium testing when appropriate can add important context to treatment decisions.
The goal is not to chase one cholesterol number. It is to understand and reduce the patient’s overall cardiometabolic risk.
GOUT + HIGH URIC ACID
Gout is more than an isolated joint problem.
Gout develops when uric acid accumulates and urate crystals form in and around joints. But elevated uric acid frequently occurs alongside insulin resistance, excess body fat, high blood pressure, fatty liver, kidney dysfunction, and other features of metabolic disease.
​
Treatment should control acute attacks when they occur while also addressing the factors that may be contributing to persistently elevated uric acid and recurrent gout over time.
Uric acid + kidney function
Serum uric acid, kidney function, hydration, medications, and other clinical factors help determine why uric acid may be elevated and how aggressively it needs to be managed.
Metabolic context
Insulin resistance, excess body fat, blood pressure, triglycerides, glucose regulation, alcohol intake, and high intake of fructose from added sugars and sugary drinks can all contribute important context in patients with gout.
Prevent recurrence
Acute treatment matters, but the longer-term goal is to reduce recurrent attacks, lower uric acid when indicated, and improve the metabolic environment associated with gout.
The goal is not only fewer flares. It is better uric acid control and better metabolic health.
CARDIOMETABOLIC RISK
Cardiovascular risk is shaped by more than one lab value.
Blood pressure, glucose regulation, insulin resistance, body composition, triglycerides, cholesterol-related markers, inflammation, smoking, family history, and other clinical factors can all influence long-term cardiovascular risk.
​
I look at these factors together rather than relying on a single number to define risk or treatment.
Metabolic health
Glucose regulation, insulin resistance, waist circumference, blood pressure, fatty liver, and triglycerides help define the broader metabolic risk pattern.
Inflammation + lifestyle
Smoking, sleep, physical activity, inflammation, alcohol intake, and other lifestyle factors can meaningfully influence risk over time.
Lipid-related risk
LDL-related markers, ApoB, Lp(a), triglycerides, and HDL can provide additional context about atherosclerotic risk.
Imaging when appropriate
Coronary artery calcium testing and other imaging can sometimes provide useful additional information when treatment decisions are uncertain.
The goal is not to treat isolated numbers. It is to understand the whole risk picture and reduce the factors that matter most.
THE COMMON THREAD
Different diagnoses can reflect the same underlying metabolic problem.
Obesity, insulin resistance, type 2 diabetes, high blood pressure, fatty liver, high triglycerides, gout, and cardiovascular risk often overlap because they share many of the same metabolic drivers.
​
That is why I do not approach them as completely separate problems. I look for the patterns connecting them, identify what is most important in the individual patient, and build the treatment plan around that.
When the underlying metabolic health improves, multiple conditions can improve together.
READY TO TAKE THE NEXT STEP?
If these conditions are part of your health picture, choose the care path that fits where you live.
I work with patients in the United States by telehealth and see patients in person in Dubai, using the same clinical approach focused on metabolic health, nutrition, testing, and individualized treatment.